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Abstract
Introduction: Steroid cell tumors are microscopically characterized by abundant eosinophilic or vacuolated
cytoplasm that is often positive for fat stains. These tumors could be of ovarian or ectopic adrenal origin. We
present a rare case of a steroid cell tumor arising from the pelvic mesentery.
Case presentation: A 31-year-old Asian woman was undergoing treatment for infertility and virilizing symptoms.
She underwent laparoscopy followed by laprotomy for a suspected ovarian cyst/pelvic mass. During the laprotomy,
a mass of 9 × 7 cm was detected in the pelvic mesentery.
Microscopically, the tumor showed large cells arranged predominantly in sheets with abundant granular cytoplasm
and large vesicular nuclei with prominent nucleoli. The tumor was seen infiltrating surrounding adipose tissue.
Immunohistochemically, the tumor cells showed strong positivity for kertain, inhibin, vimentine, melan-A, neuron-
specific enolase, chromogranin, and S-100 protein and focal positivity to epithelial membrane antigen. An MIB1
index showed 4% nuclear positivity. The tumor cells were negative for calretinin, desmin, and muscle actin.
Considering the clinical findings, histomorphology, and immunohistochemistry, we made the diagnosis of
extraovarian and extra-adrenal steroid cell tumor (not otherwise specified) of the pelvic mesentery.
Conclusions: We report an extremely rare case of an extraovarian and extra-adrenal steroid cell tumor of the
pelvic mesentery. The tumor was a cause of virilizing symptoms and infertility in the patient. Surgical removal of
the tumor reverted the symptoms of virilization, and the patient subsequently conceived. Steroid cell tumors
should be considered in differential diagnosis among women presenting with infertility and symptoms of
virilization.
Introduction
Steroid cell tumors are rare sex cord neoplasms that
account for less than 0.1% of all ovarian tumors. These
tumors are composed of large round or polyhydral cells
that resemble lutein, Leydig, and adrenocortical cells [1].
The majority of them produce steroids, particularly testos-
terone, and present with virilizing symptoms such as hir-
sutism, temporal balding, and amenorrhea [2-5]. They
have been divided into three subtypes according to their
cell of origin: stromal luteoma arising from ovarian
stroma, Leydig cell tumor arising from Leydig cells in the
hilus, and steroid cell tumor (not otherwise specified, or
NOS) when the lineage of the tumor is unknown [1,2].
NOS tumors account for approximately half of the steroid
cell tumors, occur at any age, and often are associated
with virilization, although few of the tumors are also asso-
ciated with estrogenic manifestations. Besides having an
ovarian origin, these tumors could have an ectopic adrenal
origin [1,6-8]. In this report, we present a rare case of a
mesenteric steroid cell tumor.
Case presentation
A 31-year-old Asian woman presented in our institute
with a history of pelvic mass. Prior to this consultation,
she was undergoing treatment for infertility. She under-
went laparoscopy followed by laprotomy in a non-oncolo-
gical center for a suspected right ovarian cyst/pelvic mass.
During the laprotomy, a mass of 9 × 7 cm was detected in
the pelvic mesentery. The tumor was hemorrhagic, dark
red/brown in color, and soft to firm in consistency and
was seen arising from the pelvic colonic mesentery. The
adjacent bowel lumen, uterus, and both tubes and ovaries
* Correspondence: kmurhekar@rediffmail.com
1Department of Pathology, Cancer Institute (WIA), Adyar, Chennai, Tamil
Nadu, 600 020, India
Full list of author information is available at the end of the article
Murhekar et al. Journal of Medical Case Reports 2011, 5:517
http://www.jmedicalcasereports.com/content/5/1/517 JOURNAL OF MEDICAL
CASE REPORTS
© 2011 Murhekar et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.were normal. There was no evidence of adhesions, tuber-
culosis, or endometriosis in the pelvic peritoneum. The
mass was excised.
The patient came to our institute for further manage-
ment. Her ECOG performance status was grade-1 and she
had no supraclavicular lymphadenopathy and there was
no palpable mass or free fluid in her abdomen. The results
of per-vaginal and per-rectal examinations were normal.
She had been married for two years and was undergoing
treatment for infertility for the previous six months when
she noticed facial hairs (features of hirsutism) and a deep
husky voice. Her periods were regular for the last year and
a half but were reduced to spotting lasting one day every
35 to 40 days during the last six months. When she came
to our institute a month and a half after the surgical exci-
sion, the facial hairs had disappeared, her periods had nor-
malized to a regular 3/28-day cycle, and she had a normal
feminine voice.
Her hemogram and chest X-ray were normal. Her
serum human chorionic gonadotropin, alpha fetoprotein,
and lactate dehydrogenase levels were 0.29 mIU/ml, 3 ng/
mL and 458IU/L respectively. On computed tomography
scan, liver, gall bladder, pancreas, spleen, and kidneys were
normal. Both the adrenals as well as ovaries were normal,
and no mass lesions were identified. There was no para-
aortic lymphadenopathy and no free fluid in the perito-
neum or pleural cavity.
We reviewed the slides of the excised pelvic mass.
Microscopically, the tumor showed cells arranged predo-
minantly in sheets. The cells were large and round or
polygonal with abundant granular cytoplasm (Figure 1).
T h en u c l e iw e r el a r g ev e s i c u l a rn u c l e iw i t hp r o m i n e n t
nucleoli and showed a moderate degree of nuclear pleo-
morphism. The tumor was seen infiltrating surrounding
adipose tissue. Immunohistochemically, the tumor cells
showed strong positivity for kertain, inhibin (Figure 2),
vimentine, melan-A, neuron-specific enolase, chromogra-
nin, and S-100 protein and focal positivity to epithelial
membrane antigen (EMA) (Figure 3). An MIB1 index
showed 4% nuclear positivity. The tumor cells were nega-
tive for calretinin, desmin, muscle actin, and CK7. Consid-
ering the clinical findings, histomorphology, and
immunohistochemistry, we made the diagnosis of extrao-
varian and extra-adrenal steroid cell tumor (NOS) of the
pelvic mesentery.
Discussion
The steroid cell tumors could be of ovarian or ectopic
adrenal origin, whereas few cases of extraovarian and
extra-adrenal origin have been reported in the literature
[1,4,5,7]. However, in the majority of the cases, the exact
origin of the tumor remains undecided [1].
Microscopically, steroid cell tumors are characterized
by the presence of diffusely arranged cells with abundant
granular eosinophilic or vacuolated cytoplasm that is
often positive for fat stains. Besides these microscopic
features, immunohistochemistry is very useful in diagnos-
ing these tumors correctly.
Zhao and colleagues [9] conducted a study to find the
most sensitive and robust immunohistochemical markers
for different categories of sex cord tumors. A number of
immunohistochemical markers were reviewed for their
utility in the differential diagnosis of sex cord-stromal
tumors, and inhibin and calretinin were found to be most
useful in differentiating sex cord-stromal from non-sex
cord-stromal tumors [9]. In an immunohistochemical
study on 215 ovarian tumors, caleritinin was found to be a
sensitive marker for sex cord tumors; however, it was a
less specific marker than inhibin in differentiating these
stromal tumors from fibrous neoplasms [10]. Most of the
Figure 1 Steroid cell tumor. Stain: hematoxylin and eosin.
Magnification: ×10.
Figure 2 Tumor cells showing strong positivity for inhibin.
Stain: hematoxylin and eosin. Magnification: ×10.
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[9,11,12]. However, some authors have also reported calre-
tinin-negative steroid cell tumors [13,14].
We made the diagnosis of sex cord steroid cell tumor
on the basis of microscopic pictures as well as immune
reactivity to inhibin. Negative reaction to CK7 was in
support of a diagnosis of sex cord tumor as these
tumors are generally negative for CK7 [9,15]. Many of
the sex cord tumors are also negative to EMA [9,15],
although a small subset of tumors could be positive to
EMA [9]. Focal positivity to EMA was reported in a
case of steroid cell tumor [14]. Focal EMA positivity
observed in our case is in concurrence with other
reported cases [14].
Adrenocortical carcinoma and paraganglioma are the
close differential diagnosis of steroid cell tumors. We
ruled out the diagnosis of adrenocortical carcinoma and
paraganglioma on the basis of immunohistochemical mar-
kers. Adrenocortical carcinomas are negative to EMA,
keratin, and chromogranin, whereas the tumor in the pre-
sent case was positive for these markers. An absence of
mass lesions in bilateral adrenals further ruled out the
diagnosis of adrenocortical carcinoma. Paragangliomas are
negative to keratin and melan-A, whereas the tumor in
the present case was positive for these markers.
Most steroid cell tumors cause virilizing syndromes.
Most of these tumors are often associated with elevated
levels of testosterone and androstenedione, whereas
others are associated with estrogenic and progestogenic
manifestations [6]. Since our patient was operated on
elsewhere, we could not conduct hormonal assays. How-
ever, the clinical presentation, including the symptoms of
virilization, supports the diagnosis of steroid hormone
secretion. Also, within two months of the removal of the
pelvic mass, symptoms of virilization disappeared.
Steroid cell tumors (NOS) also need to be differen-
tiated from other ovarian tumors - such as the juvenile
granulosa cell tumor with luteinization, lutinized the-
coma, and lipid-rich Sertoli cell tumor - in which prolif-
eration of steroid hormone-producing cells occurs as a
secondary event [1,2]. A predominantly diffuse pattern in
luteinized granulosa cells might suggest the diagnosis of
steroid cell tumor, but the uniformity of the pattern and
cytologic feature of the steroid cell tumor would be unu-
sual for the juvenile granulosa cell tumor, which almost
always contains diagnostic areas with follicles. When the
lutein cells in a lutinized thecoma are extensive, a steroid
cell tumor (NOS) may be simulated. Although some ster-
oid cell tumors (NOS) might have a fibromatous compo-
nent like that of thecoma, the fibromatous component in
NOS tumors accounts for less than 10% of the tumor.
Differentiating a lipid-rich Sertoli cell tumor with a dif-
fuse pattern from a steroid cell tumor (NOS) depends
mostly on identifying areas with a tubular pattern in the
former [1,2].
The incidence of clinical malignancy among the steroid
cell tumors has been documented. Hayes and Scully [3]
identified five pathologic features that are highly asso-
ciated with malignancy: (a) size (diameter of 7 cm or
greater; 78% malignant), (b) mitoses (two or more
mitoses per 10 high-power fields; 92% malignant), (c)
necrosis (86% malignant), (d) hemorrhage (77% malig-
nant), and (e) grade 2 or 3 nuclear atypia (64% malig-
nant). The size of the tumor, presence of hemorrhage,
and nuclear pleomorphism in the present case were sug-
gestive of a malignant nature.
By extrapolation from ovarian steroid cell tumors
(NOS), treatment of extraovarian steroid cell tumors is
primarily surgical [4]. In the present case, the tumor was
excised in a non-oncological setting. Further management
issues included whether to re-excise the remnant mesen-
tery to prevent local relapse and administer adjuvant che-
motherapy to prevent distant relapse. As we were
discussing these issues, our patient reported missing her
period. Her urine pregnancy test was positive, and her
serum beta-human chorionic gonadotropin level was 3280
mIU/mL. Our patient chose to be on regular follow-up
with us and is under the care of a local obstetrician for her
pregnancy.
Conclusions
The present case was a rare report of an extraovarian and
extra-adrenal steroid cell tumor of the pelvic mesentery.
The tumor was a cause of virilizing symptoms and infer-
tility in our patient. Surgical removal of the tumor
reverted the symptoms of virilization, and our patient
subsequently conceived. Steroid cell tumors should be
considered in differential diagnosis among women pre-
senting with infertility and symptoms of virilization.
Figure 3 Tumor cells showing positivity to epithelial
membrane antigen.
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Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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